N
Nicolas Rapin
Researcher at University of Copenhagen
Publications - 50
Citations - 5496
Nicolas Rapin is an academic researcher from University of Copenhagen. The author has contributed to research in topics: CEBPA & Transcription factor. The author has an hindex of 25, co-authored 49 publications receiving 4191 citations. Previous affiliations of Nicolas Rapin include Technical University of Denmark & Finsen Laboratory.
Papers
More filters
Journal ArticleDOI
An atlas of active enhancers across human cell types and tissues
Robin Andersson,Claudia Gebhard,Irene Miguel-Escalada,Ilka Hoof,Jette Bornholdt,Mette Boyd,Yun Chen,Xiaobei Zhao,Xiaobei Zhao,Christian Schmidl,Takahiro Suzuki,Evgenia Ntini,Erik Arner,Eivind Valen,Eivind Valen,Kang Li,Lucia Schwarzfischer,Dagmar Glatz,Johanna Raithel,Berit Lilje,Nicolas Rapin,Frederik Otzen Bagger,Mette Rose Jørgensen,Peter Refsing Andersen,Nicolas Bertin,Owen J. L. Rackham,A. Maxwell Burroughs,J Kenneth Baillie,Yuri Ishizu,Yuri Shimizu,Erina Furuhata,Shiori Maeda,Yutaka Negishi,Christopher J. Mungall,Terrence F. Meehan,Timo Lassmann,Masayoshi Itoh,Hideya Kawaji,Naoto Kondo,Jun Kawai,Andreas Lennartsson,Carsten O. Daub,Peter Heutink,David A. Hume,Torben Heick Jensen,Harukazu Suzuki,Yoshihide Hayashizaki,Ferenc Müller,Alistair R. R. Forrest,Piero Carninci,Michael Rehli,Albin Sandelin +51 more
TL;DR: It is shown that enhancers share properties with CpG-poor messenger RNA promoters but produce bidirectional, exosome-sensitive, relatively short unspliced RNAs, the generation of which is strongly related to enhancer activity.
Journal ArticleDOI
Computational Immunology Meets Bioinformatics: The Use of Prediction Tools for Molecular Binding in the Simulation of the Immune System
TL;DR: An agent-based simulator of the immune response is extended such that it represents pathogens, as well as lymphocytes receptors, by means of their amino acid sequences and makes use of bioinformatics methods for T and B cell epitope prediction, which shows that the simulator produces dynamics that are stable and consistent with basic immunological knowledge.
Journal ArticleDOI
EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas
Faizaan Mohammad,Simon Weissmann,Benjamin Leblanc,Deo Prakash Pandey,Jonas W. Højfeldt,Itys Comet,Chunqin Zheng,Jens Vilstrup Johansen,Nicolas Rapin,Bo T. Porse,Andrey Tvardovskiy,Andrey Tvardovskiy,Ole N. Jensen,Ole N. Jensen,Nagore G. Olaciregui,Cinzia Lavarino,Mariona Suñol,Carmen de Torres,Jaume Mora,Angel M. Carcaboso,Kristian Helin +20 more
TL;DR: Results show that residual PRC2 activity is required for the proliferation of H3K27M-expressing DIPGs, and that inhibition of EZH2 is a potential therapeutic strategy for the treatment of these tumors.
Journal ArticleDOI
BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis.
Frederik Otzen Bagger,Damir Sasivarevic,Sina Hadi Sohi,Linea Gøricke Laursen,Sachin Pundhir,Casper Kaae Sønderby,Ole Winther,Nicolas Rapin,Bo T. Porse +8 more
TL;DR: The database now includes 23 high-quality curated data sets relevant to normal and malignant blood formation and, in addition, it has assembled and built a unique integrated data set, BloodPool, which contains more than 2000 samples assembled from six independent studies on acute myeloid leukemia.
Journal ArticleDOI
Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis
Kasper D. Rasmussen,Guangshuai Jia,Jens Vilstrup Johansen,Marianne Terndrup Pedersen,Nicolas Rapin,Frederik Otzen Bagger,Bo T. Porse,Olivier A. Bernard,Jesper Christensen,Kristian Helin +9 more
TL;DR: It is proposed that TET2 prevents leukemic transformation by protecting enhancers from aberrant DNA methylation and that it is the combined silencing of several tumor suppressor genes in Tet2 mutated hematopoietic cells that contributes to increased stem cell proliferation and leukemogenesis.